Skip to main content

Table 3 Percentages refer to complete responses

From: Study Protocol. ECSSIT – Elective Caesarean Section Syntocinon® Infusion Trial. A multi-centre randomised controlled trial of oxytocin (Syntocinon®) 5 IU bolus and placebo infusion versus oxytocin 5 IU bolus and 40 IU infusion for the control of blood loss at elective caesarean section

 

All

n = 365 (%)

Obstetricians

n = 179 (%)

Anaesthetists

n = 186 (%)

Slow bolus 5 IU oxytocin

324 (89.5)

153 (86.4)

171 (92.4)

Slow bolus 10 IU oxytocin

44 (12.1)

28 (15.6)

16 (8.6)

Additional 5 IU bolus if clinically indicated

61 (17.0)

17 (9.5)

44 (23.5)

Routine use of oxytocin infusion

72 (19.8)

33 (18.4)

39 (21.1)

Selective use of oxytocin infusion

289 (79.8)

145 (81.0)

144 (78.7)

30 IU oxytocin infusion

158 (43.3)

83 (46.4)

76 (40.9)

40 IU oxytocin infusion

192 (53.3)

90 (50.8)

102 (55.0)

  1. Approaches to the use of oxytocin at the time of caesarean section